v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
$ in Millions
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2025
€ / shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2024
€ / shares
Cash and cash equivalents $ 778   $ 855  
Accounts receivable 4,844   4,117  
Other non-current assets 2,679   2,455  
Non-current debt due after one year 13,329   12,542  
Other non-current liabilities $ 2,274   $ 2,191  
Preferred stock, par or stated value per share (in dollars per share) | $ / shares $ 0.001   $ 0.001  
Preferred stock, shares authorized (in shares) | shares 500,000,000   500,000,000  
Preferred stock, shares outstanding (in shares) | shares 10,000   10,000  
Common stock, par or stated value per share (in dollars per share) | $ / shares $ 0.001   $ 0.001  
Common stock, shares authorized (in shares) | shares 9,500,000,000   9,500,000,000  
Common stock, shares outstanding (in shares) | shares 522,058,394   520,444,261  
Deferred stock, par or stated value per share (in euro per share) | € / shares   € 1   € 1
Deferred stock, shares authorized (in shares) | shares 25,000   25,000  
Deferred stock, shares outstanding (in shares) | shares 0   25,000  
Treasury stock, common (in shares) | shares 1,459,832   2,037,589  
Variable interest entity, primary beneficiary        
Cash and cash equivalents $ 5   $ 2  
Accounts receivable 893   767  
Other non-current assets 389   389  
Non-current debt due after one year 296   8  
Other non-current liabilities $ 334   $ 335